Restor Dent Endod.  2021 May;46(2):e21. 10.5395/rde.2021.46.e21.

Biological assessment of a new readyto-use hydraulic sealer

• Benetti F
• Gomes-Filho JE
• Azevedo-Queiroz IOd
• Carminatti M
• Conti LC
• Reis-Prado AHd
• Oliveira SHPd
• Ervolino E
• Dezan-Júnior E
• Cintra LTA

• KMID: 2548065
• DOI: http://doi.org/10.5395/rde.2021.46.e21

Abstract

Objectives
This study compared the cytotoxicity, biocompatibility, and tenascin immunolabeling of a new ready-to-use hydraulic sealer (Bio-C Sealer) with MTA-Fillapex and white MTA-Angelus.
Materials and Methods
L929 fibroblasts were cultivated and exposed to undiluted and diluted material extracts. Polyethylene tubes with or without (the control) the materials were implanted into the dorsa of rats. At 7 days and 30 days, the rats were euthanized, and the specimens were prepared for analysis; inflammation and immunolabeling were measured, and statistical analysis was performed (p < 0.05).
Results
MTA-Fillapex exhibited greater cytotoxicity than the other materials at all time points (p < 0.05). The undiluted Bio-C Sealer exhibited greater cytocompatibility at 6 and 48 hours than white MTA-Angelus, with higher cell viability than in the control (p < 0.05). White MTA-Angelus displayed higher cell viability than the control at 24 hours, and the one-half dilution displayed similar results at both 6 and 48 hours (p < 0.05). At 7 days and 30 days, the groups exhibited moderate inflammation with thick fibrous capsules and mild inflammation with thin fibrous capsules, respectively (p > 0.05). At 7 days, moderate to strong immunolabeling was observed (p > 0.05). After 30 days, the control and MTAFillapex groups exhibited strong immunolabeling, the white MTA-Angelus group exhibited moderate immunolabeling (p > 0.05), and the Bio-C Sealer group exhibited low-to-moderate immunolabeling, differing significantly from the control (p < 0.05).
Conclusions
Bio-C Sealer and white MTA-Angelus exhibited greater cytocompatibility than MTA-Fillapex; all materials displayed adequate biocompatibility and induced tenascin immunolabeling.

Keyword

Biocompatibility; Cytotoxicity; Hydraulic sealer; Mineral trioxide aggregate; Tenascin

Figure

• 

  Figure 1 Cell viability for MTA-Fillapex, Bio-C Sealer, and white MTA-Angelus.A-DThe same uppercase letters indicate a lack of statistically significant differences among the materials at the same period and in the same dilution. a-cThe same lowercase letters indicate a lack of statistically significant differences among extract dilutions of the same material at the same time point.

• 

  Figure 2 Representative images of the tissue response in terms of inflammatory infiltration and immunolabeling of tenascin. (A-L) Under the highest magnification, the white arrowheads indicate inflammatory cells, the yellow arrows indicate blood vessels, and asterisks indicate the fibrous capsule. The blue arrowheads indicate immunolabeling in the cytoplasm of the cells and in the extracellular matrix. At 7 days: (A, E) control, (B, F) MTA-Fillapex, (C, G) Bio-C Sealer, and (D, H) white MTA-Angelus displaying mild inflammatory cell infiltration and a thick fibrous capsule; (I) the control group with strong immunolabeling and (J) MTA-Fillapex, (K) Bio-C Sealer, and (L) the white MTA-Angelus groups with moderate immunolabeling. (M-X) At 30 days: (M, Q) the control, (N, R) MTA-Fillapex, (O, S) Bio-C Sealer, and (P, T) white MTA-Angelus, with mild inflammatory infiltration and a thin fibrous capsule; (U) control and (V) MTA-Fillapex groups with strong immunolabeling, (W) Bio-C Sealer with low immunolabeling, and (X) white MTA-Angelus with moderate immunolabeling. (A-D, M-P) The histological sections were stained using hematoxylin and eosin staining (×100 magnification). (E-H, Q-T) The histological sections were stained using hematoxylin and eosin staining (×400 magnification). (I-L, U-X) Results of the immunohistochemical analysis with regard to tenascin (×400 magnification).

Reference

1. Vouzara T, Dimosiari G, Koulaouzidou EA, Economides N. Cytotoxicity of a new calcium silicate endodontic sealer. J Endod. 2018; 44:849–852. PMID: 29550005.

2. Shie MY, Chang HC, Ding SJ. Effects of altering the Si/Ca molar ratio of a calcium silicate cement on in vitro cell attachment. Int Endod J. 2012; 45:337–345. PMID: 22044218.

3. Saghiri MA, Orangi J, Asatourian A, Gutmann JL, Garcia-Godoy F, Lotfi M, Sheibani N. Calcium silicate-based cements and functional impacts of various constituents. Dent Mater J. 2017; 36:8–18. PMID: 27773894.

4. Han L, Okiji T. Uptake of calcium and silicon released from calcium silicate-based endodontic materials into root canal dentine. Int Endod J. 2011; 44:1081–1087. PMID: 21777256.

5. Reyes-Carmona JF, Felippe MS, Felippe WT. The biomineralization ability of mineral trioxide aggregate and Portland cement on dentin enhances the push-out strength. J Endod. 2010; 36:286–291. PMID: 20113792.

6. Vitti RP, Prati C, Silva EJ, Sinhoreti MA, Zanchi CH, de Souza e Silva MG, Ogliari FA, Piva E, Gandolfi MG. Physical properties of MTA Fillapex sealer. J Endod. 2013; 39:915–918. PMID: 23791263.

7. Zhou HM, Du TF, Shen Y, Wang ZJ, Zheng YF, Haapasalo M. In vitro cytotoxicity of calcium silicate-containing endodontic sealers. J Endod. 2015; 41:56–61. PMID: 25442721.

8. Collado-González M, Tomás-Catalá CJ, Oñate-Sánchez RE, Moraleda JM, Rodríguez-Lozano FJ. Cytotoxicity of GuttaFlow Bioseal, GuttaFlow2, Mta Fillapex, and Ah Plus on human periodontal ligament stem cells. J Endod. 2017; 43:816–822. PMID: 28343929.

9. Gomes-Filho JE, Watanabe S, Lodi CS, Cintra LT, Nery MJ, Filho JA, Dezan E Jr, Bernabé PF. Rat tissue reaction to MTA Fillapex^® . Dent Traumatol. 2012; 28:452–456. PMID: 22151741.

10. Salles LP, Gomes-Cornélio AL, Guimarães FC, Herrera BS, Bao SN, Rossa-Junior C, Guerreiro-Tanomaru JM, Tanomaru-Filho M. Mineral trioxide aggregate-based endodontic sealer stimulates hydroxyapatite nucleation in human osteoblast-like cell culture. J Endod. 2012; 38:971–976. PMID: 22703663.

11. Costa F, Sousa Gomes P, Fernandes MH. Osteogenic and angiogenic response to calcium silicate-based endodontic sealers. J Endod. 2016; 42:113–119. PMID: 26577874.

12. Grossman LI. Endodontic practice. 10th ed. Philadelphia, PA: Lea & Febiger;1982.

13. Cintra LTA, Benetti F, de Azevedo Queiroz ÍO, Ferreira LL, Massunari L, Bueno CRE, de Oliveira SHP, Gomes-Filho JE. Evaluation of the cytotoxicity and biocompatibility of new resin epoxy-based endodontic sealer containing calcium hydroxide. J Endod. 2017; 43:2088–2092. PMID: 29032822.

14. Andrade AS, Silva GF, Camilleri J, Cerri ES, Guerreiro-Tanomaru JM, Cerri PS, Tanomaru-Filho M. Tissue response and immunoexpression of interleukin 6 promoted by tricalcium silicate-based repair materials after subcutaneous implantation in rats. J Endod. 2018; 44:458–463. PMID: 29398089.

15. Cosme-Silva L, Benetti F, Dal-Fabbro R, Gomes Filho JE, Sakai VT, Cintra LTA, Alvarez N, Ervolino E, Viola NV. Biocompatibility and biomineralization ability of Bio-C Pulpecto. A histological and immunohistochemical study. Int J Paediatr Dent. 2019; 29:352–360. PMID: 30620114.

16. Cosme-Silva L, Gomes-Filho JE, Benetti F, Dal-Fabbro R, Sakai VT, Cintra LTA, Ervolino E, Viola NV. Biocompatibility and immunohistochemical evaluation of a new calcium silicate-based cement, Bio-C Pulpo. Int Endod J. 2019; 52:689–700. PMID: 30515845.

17. da Fonseca TS, Silva GF, Guerreiro-Tanomaru JM, Sasso-Cerri E, Tanomaru-Filho M, Cerri PS. Mast cells and immunoexpression of FGF-1 and Ki-67 in rat subcutaneous tissue following the implantation of Biodentine and MTA Angelus. Int Endod J. 2019; 52:54–67. PMID: 29975794.

18. Zarrabi MH, Javidi M, Jafarian AH, Joushan B. Immunohistochemical expression of fibronectin and tenascin in human tooth pulp capped with mineral trioxide aggregate and a novel endodontic cement. J Endod. 2011; 37:1613–1618. PMID: 22099892.

19. Moradi S, Saghravanian N, Moushekhian S, Fatemi S, Forghani M. Immunohistochemical evaluation of fibronectin and tenascin following direct pulp capping with mineral trioxide aggregate, platelet-rich plasma and propolis in dogs’ teeth. Iran Endod J. 2015; 10:188–192. PMID: 26213542.

20. Thesleff I, Mackie E, Vainio S, Chiquet-Ehrismann R. Changes in the distribution of tenascin during tooth development. Development. 1987; 101:289–296. PMID: 2451586.

21. Piva E, Tarquínio SB, Demarco FF, Silva AF, de Araújo VC. Immunohistochemical expression of fibronectin and tenascin after direct pulp capping with calcium hydroxide. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102:e66–e71. PMID: 16997097.

22. Cintra LTA, Benetti F, de Azevedo Queiroz ÍO, de Araújo Lopes JM, Penha de Oliveira SH, Sivieri Araújo G, Gomes-Filho JE. Cytotoxicity, biocompatibility, and biomineralization of the new high-plasticity MTA material. J Endod. 2017; 43:774–778. PMID: 28320539.

23. International Organization for Standardization (ISO). ISO 10993-5: Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity. Geneva: ISO;2009.

24. Benetti F, Briso ALF, Carminatti M, de Araújo Lopes JM, Barbosa JG, Ervolino E, Gomes-Filho JE, Cintra LTA. The presence of osteocalcin, osteopontin and reactive oxygen species-positive cells in pulp tissue after dental bleaching. Int Endod J. 2019; 52:665–675. PMID: 30488465.

25. Jung S, Sielker S, Hanisch MR, Libricht V, Schäfer E, Dammaschke T. Cytotoxic effects of four different root canal sealers on human osteoblasts. PLoS One. 2018; 13:e0194467. PMID: 29579090.

26. Victoria-Escandell A, Ibañez-Cabellos JS, de Cutanda SB, Berenguer-Pascual E, Beltrán-García J, García-López E, Pallardó FV, García-Giménez JL, Pallarés-Sabater A, Zarzosa-López I, Monterde M. Cellular responses in human dental pulp stem cells treated with three endodontic materials. Stem Cells Int. 2017; 2017:8920356. PMID: 28751918.

27. Benetti F, Queiroz ÍOA, Cosme-Silva L, Conti LC, Oliveira SHP, Cintra LTA. Cytotoxicity, biocompatibility and biomineralization of a new ready-for-use bioceramic repair material. Braz Dent J. 2019; 30:325–332. PMID: 31340221.

28. Titushkin I, Cho M. Modulation of cellular mechanics during osteogenic differentiation of human mesenchymal stem cells. Biophys J. 2007; 93:3693–3702. PMID: 17675345.

29. Silva EJ, Carvalho NK, Ronconi CT, De-Deus G, Zuolo ML, Zaia AA. Cytotoxicity profile of endodontic sealers provided by 3D cell culture experimental model. Braz Dent J. 2016; 27:652–656. PMID: 27982174.

30. International Organization for Standardization (ISO). ISO 10993-6: Biological evaluation of medical devices - Part 6: Testes for local effects after implantation. Geneva: ISO;2016.

31. Saraiva JA, da Fonseca TS, da Silva GF, Sasso-Cerri E, Guerreiro-Tanomaru JM, Tanomaru-Filho M, Cerri PS. Reduced interleukin-6 immunoexpression and birefringent collagen formation indicate that MTA Plus and MTA Fillapex are biocompatible. Biomed Mater. 2018; 13:035002. PMID: 29242419.

32. Monteiro Bramante C, Demarchi AC, de Moraes IG, Bernadineli N, Garcia RB, Spångberg LS, Duarte MA. Presence of arsenic in different types of MTA and white and gray Portland cement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106:909–913. PMID: 18835535.

33. Demirkaya K, Can Demirdöğen B, Öncel Torun Z, Erdem O, Çetinkaya S, Akay C. In vivo evaluation of the effects of hydraulic calcium silicate dental cements on plasma and liver aluminium levels in rats. Eur J Oral Sci. 2016; 124:75–81. PMID: 26706154.

34. Demirkaya K, Demirdöğen BC, Torun ZO, Erdem O, Çırak E, Tunca YM. Brain aluminium accumulation and oxidative stress in the presence of calcium silicate dental cements. Hum Exp Toxicol. 2017; 36:1071–1080. PMID: 27895098.

35. Hirschman WR, Wheater MA, Bringas JS, Hoen MM. Cytotoxicity comparison of three current direct pulp-capping agents with a new bioceramic root repair putty. J Endod. 2012; 38:385–388. PMID: 22341080.

36. Lessa FC, Aranha AM, Hebling J, Costa CA. Cytotoxic effects of White-MTA and MTA-Bio cements on odontoblast-like cells (MDPC-23). Braz Dent J. 2010; 21:24–31. PMID: 20464317.

37. Zordan-Bronzel CL, Esteves Torres FF, Tanomaru-Filho M, Chávez-Andrade GM, Bosso-Martelo R, Guerreiro-Tanomaru JM. Evaluation of physicochemical properties of a new calcium silicate-based sealer, Bio-C Sealer. J Endod. 2019; 45:1248–1252. PMID: 31447172.

38. Castro-Raucci LMS, Teixeira LN, Oliveira IR, Raucci-Neto W, Jacobovitz M, Rosa AL, de Oliveira PT. Osteogenic cell response to calcium aluminate-based cement. Int Endod J. 2017; 50:771–779. PMID: 27521570.

39. Garcia Lda F, Huck C, Menezes de Oliveira L, de Souza PP, de Souza Costa CA. Biocompatibility of new calcium aluminate cement: tissue reaction and expression of inflammatory mediators and cytokines. J Endod. 2014; 40:2024–2029. PMID: 25266467.

40. Bernabé PF, Gomes-Filho JE, Rocha WC, Nery MJ, Otoboni-Filho JA, Dezan-Júnior E. Histological evaluation of MTA as a root-end filling material. Int Endod J. 2007; 40:758–765. PMID: 17714469.

41. Silva GF, Guerreiro-Tanomaru JM, da Fonseca TS, Bernardi MIB, Sasso-Cerri E, Tanomaru-Filho M, Cerri PS. Zirconium oxide and niobium oxide used as radiopacifiers in a calcium silicate-based material stimulate fibroblast proliferation and collagen formation. Int Endod J. 2017; 50(Supplement 2):e95–e108. PMID: 28470859.

42. Chiang TY, Ding SJ. Comparative physicochemical and biocompatible properties of radiopaque dicalcium silicate cement and mineral trioxide aggregate. J Endod. 2010; 36:1683–1687. PMID: 20850678.

43. Min KS, Chang HS, Bae JM, Park SH, Hong CU, Kim EC. The induction of heme oxygenase-1 modulates bismuth oxide-induced cytotoxicity in human dental pulp cells. J Endod. 2007; 33:1342–1346. PMID: 17963960.

44. Kebudi Benezra M, Schembri Wismayer P, Camilleri J. Interfacial characteristics and cytocompatibility of hydraulic sealer cements. J Endod. 2018; 44:1007–1017. PMID: 29398087.